This page holds a finished PA-650 Week 6 harm and benefit balance: two sides built from different sources, with who carries each and when it arrives written down. Searches like "pa 650 week 6 assignment example", "pa650 week 6 sample" and "pa-650 week 6 example" land here.
What a finished PA-650 Week 6 harm and benefit balance looks like
Two columns that refuse to be added together, and a paragraph explaining the refusal. The benefit side is short and comes from the trials already in the table. The harm side is longer and comes from somewhere else, because a trial sized to find a benefit picks up harms as whatever happened to be reported, so registries, long follow-up and case reports do the work instead. Each harm carries three things: who it lands on, how soon, and whether it can be undone. The comparison arm gets its own harms rather than sitting at zero. A short block covers the person who was never going to benefit and was exposed anyway, and another covers the testing that follows a result nobody expected.
How a PA-650 Week 6 example is structured
A supplied two-column template governs the layout and changes none of the reasoning below. The benefit side opens, stated in whatever the project has been counting, with its measurement period attached. The harm side follows in the same period wherever that is possible and says plainly where it is not, since most harm figures come from longer observation than any trial ran. Each harm is then sorted, first by who carries it and second by whether it reverses. A separate passage handles the harms of the comparison, because an option is only better than something, and that something costs too. Next comes the asymmetry paragraph: how confident each side is, and why the harm column is usually the less certain of the two. The balance closes by naming the patient for whom the two sides come out differently.
Two sides, two sources
Benefit comes from the trials; harm mostly comes from longer observation elsewhere. The example names where each column was built from rather than implying one study produced both.
Who carries it
Every harm entry names the person it lands on: the treated patient, the one who was screened for nothing, the one sent for a second test.
How soon, and can it be undone
A harm today weighed against a benefit in five years is not a subtraction. Each entry carries its timing and whether the damage reverses.
The comparison has harms too
Waiting, referring and declining all cost somebody something. A balance leaving the alternative at zero has decided the question before weighing it.
The asymmetry, stated
The paragraph that carries the section says how certain each column is. Harm figures are usually the softer of the two, and saying so is stronger than correcting for it.
Where marks go in PA-650 Week 6
The failure with the biggest price is a harm side assembled only from what the trials happened to report, which limits harm without saying so to whatever a study of that length could detect. Sitting just under it is a balance that subtracts, arriving at a net figure from two columns drawn on different clocks and different populations. Alongside those sits the comparison treated as costless, so declining or delaying appears on the page with nothing against it. Then several that recur. Harm listed with nobody attached, so a reader cannot tell who is exposed. No note on which harms undo themselves and which do not. And a section that reaches a conclusion the recommendation then ignores, which is the inconsistency a clinical reader finds first.
Get a PA-650 Week 6 example written to your instructions
Send the Week 6 instructions with your evidence table if you have one, and a custom harm and benefit balance written to your rubric arrives inside 24-48h, the first one free. Tell the desk whether your section counts cost and burden as harms, because that single answer changes half of what goes on the page.
PA-650 Week 6 questions, answered
How far does harm go? Does cost count?
Most rubrics on this course accept anything the patient bears, and the stronger documents include it: money paid, appointments taken out of a working week, a result that starts a chain of further testing. Say which of those your section names, since a few restrict the section to clinical adverse events. Where yours does not, the wider account usually reads as the more honest one.
What if the harms are not reported anywhere?
Then the absence goes into the section in exactly those words. Name what you looked in, say that nothing counted it, and state what would have to be collected before anybody could weigh the option properly. A project admitting that the harm side is unmeasured argues better than one filling the column from a different condition and hoping nobody checks.
Does the balance have to reach a verdict?
Many sections ask for one here and many hold it back until the recommendation. Either way the section should end by naming the kind of patient for whom the two sides come out on opposite sides, because a balance producing the same answer for everybody in the population has probably drawn the population too broadly or weighed only one column.